Earlier today, the National Institutes of Health (NIH) released treatment guidelines for coronavirus disease 2019 (COVID-19). Susan Davis, clinical professor of pharmacy practice in Wayne State University’s Eugene Applebaum College of Pharmacy and Health Sciences and an infectious diseases pharmacy specialist at Henry Ford Hospital, serves on the NIH's COVID-19 Treatment Guidelines Panel that was convened in late March by Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
The panel is tasked with providing up-to-date information to clinicians about the treatment of patients with COVID-19. Davis represents the Society of Infectious Disease Pharmacists and is one of six pharmacists serving on the panel, which is composed of academicians, clinicians, and representatives from multiple professional societies and government agencies. The COVID-19 pandemic is a rapidly changing situation with many evolving questions. The guidelines provide valuable information and context to assist those making treatment decisions. The panel's full set of guidelines is available here.
Davis is an expert in antimicrobial stewardship and antibiotic resistance – a research area Wayne State is particularly well known for. The field of infectious diseases pharmacotherapy has deep roots in Detroit and at Wayne State, whose faculty and alumni have had significant impact on infectious disease pharmacy research, practice and education over the years.
“Pharmacists play a critical role in public health by assessing the safety and effectiveness of treatments and educating patients, and we are thrilled that Susan’s expertise in this realm has been recognized on a national scale,” said Catherine L. Lysack, dean of the Eugene Applebaum College of Pharmacy and Health Sciences. “We’re grateful for her considerable contributions to the COVID-19 guidelines, and for all health professionals working to innovate and advise in this time of uncertainty.”
Davis, who earned her Pharm.D. from the University of Michigan in 2002, completed a pharmacy practice residency at Detroit Receiving Hospital in 2003 and a fellowship in infectious diseases outcomes research at Wayne State in 2005. She joined WSU’s pharmacy practice faculty in 2005 with a clinical appointment at Henry Ford Health System. Her additional research interests include antimicrobial stewardship implementation, antimicrobial resistance, and improving outcomes of infectious diseases. She is currently the president-elect of the Society of Infectious Diseases Pharmacists.
